X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1599) 1599
Publication (113) 113
Conference Proceeding (73) 73
Dissertation (35) 35
Patent (30) 30
Book Chapter (20) 20
Newspaper Article (15) 15
Book Review (10) 10
Book / eBook (9) 9
Technical Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (375) 375
humans (247) 247
analysis (163) 163
male (159) 159
female (133) 133
materials science, multidisciplinary (118) 118
research (90) 90
middle aged (82) 82
nanoparticles (79) 79
adult (78) 78
chemistry, multidisciplinary (72) 72
physics, applied (67) 67
chemistry (66) 66
surgery (63) 63
aged (62) 62
microbiology (61) 61
studies (60) 60
care and treatment (58) 58
animals (57) 57
energy & fuels (56) 56
health aspects (55) 55
life sciences (55) 55
nanoscience & nanotechnology (55) 55
chemistry, physical (54) 54
multidisciplinary sciences (53) 53
permeability (51) 51
article (50) 50
environmental sciences (50) 50
geosciences, multidisciplinary (49) 49
methods (45) 45
medicine (44) 44
risk factors (44) 44
earth sciences (43) 43
mechanical properties (43) 43
physics, condensed matter (43) 43
diagnosis (41) 41
pharmacology & pharmacy (41) 41
physics (41) 41
plant sciences (41) 41
research article (41) 41
usage (41) 41
behavior (39) 39
engineering (39) 39
growth (39) 39
management (39) 39
medicine & public health (39) 39
mathematical models (38) 38
mortality (38) 38
physiological aspects (38) 38
review (38) 38
proteins (37) 37
water (37) 37
adolescent (36) 36
urology & nephrology (36) 36
biochemistry & molecular biology (35) 35
performance (35) 35
engineering, geological (34) 34
india (34) 34
young adult (33) 33
coal (32) 32
electrodes (32) 32
nanostructure (32) 32
cancer (31) 31
carbon dioxide (31) 31
child (31) 31
original (31) 31
strength (31) 31
morphology (30) 30
biotechnology & applied microbiology (29) 29
clinical neurology (29) 29
computer simulation (29) 29
neurosciences (29) 29
patients (29) 29
civil engineering (28) 28
deformation (28) 28
engineering, chemical (28) 28
geophysics/geodesy (28) 28
materials science (28) 28
model (28) 28
temperature (28) 28
therapy (28) 28
abridged index medicus (27) 27
adsorption (27) 27
engineering, electrical & electronic (27) 27
genetic aspects (27) 27
organic chemistry (27) 27
rock (27) 27
rocks (27) 27
science (27) 27
treatment outcome (27) 27
agronomy (26) 26
children (26) 26
diabetes (26) 26
enzymes (26) 26
in-vitro (26) 26
catalysis (25) 25
chemical synthesis (25) 25
chemistry, organic (25) 25
crystal structure (25) 25
disease (25) 25
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1745) 1745
Chinese (9) 9
French (5) 5
Korean (4) 4
German (1) 1
Japanese (1) 1
Portuguese (1) 1
Sinhala (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article